P was mentioned like that because it is one of the "clinical priorities". And it is. Having adequate cash to pay the CRO is a financial priority. That is a different matter and the company is pursuing "additional sources". It may need them, depending on timing. We have to keep the lights on as first priority and our cash is currently very limited.
News 
Market Data 
Discover 
AI
